Arquivamento - Art. 36 §1° da LPI
#11.2
12/03/2024
RPI 2813
Application data
Number
112019017695Type
Filing
Publication
PCT
US2018019868 The application was abandoned: the INPI technical office action was not answered in time (art. 36 of the Brazilian IP Act). The technology is in the public domain in Brazil.
Talk to a specialistLatest action published by the INPI: 12/03/2024. We update with every new RPI gazette, published weekly.
Applicants
BRISTOL-MYERS SQUIBB COMPANY
US
Inventors
A. K. (pessoa física)
US
J. L. (pessoa física)
US
K. L. (pessoa física)
US
R. G. (pessoa física)
US
IPC Classification
Priority claims
US
62/464,738 · 02/28/2017
US
62/468,527 · 03/08/2017
Abstract
A presente invenção refere-se a métodos para acentuar a resposta imune a uma vacina usando formas variantes de anticorpos anti-CTLA-4 com atividade de ADCC acentuada. As variantes dos anticorpos anti-CTLA-4 para uso na presente invenção incluem o ipilimumab não fucosilado.
Publications in the Brazilian Industrial Property Gazette (RPI).
#11.2
12/03/2024
RPI 2813
#6.23
08/20/2024
RPI 2798
#15.35
10/19/2021
RPI 2650
#1.3
04/07/2020
RPI 2570
#1.1
09/03/2019
RPI 2539
From the same holder
Same category
Patent monitoring
Receive alerts on INPI events, decisions, and expiry dates for your portfolio.